E-LIB Suche - Ergebnisse für: Pradelli, J.

1

EE494 Optimizing Treatment of Schizophrenia: Pharmacoeconom..:

Zaniolo, O. ; Pradelli, L. ; Franchi, A..
Value in Health. 26 (2023) 12 - p. S146 , 2023

Link: https://doi.org/10.1016/..

2

EE79 Cost-Utility Analyses of Glofitamab for the Treatment ..:

Bellone, M. ; Ghislieri, D. ; Pradelli, L...
Value in Health. 26 (2023) 12 - p. S65 , 2023

Link: https://doi.org/10.1016/..

3

SA36 Safety, Efficacy, Quality of Life, and Treatment Dynam..:

Povero, M. ; Pradelli, L. ; Ronci, G....
Value in Health. 26 (2023) 12 - p. S548 , 2023

Link: https://doi.org/10.1016/..

4

EE483 A Cost-Impact Analysis of a Novel Diagnostic Test to ..:

Porta, C. ; Pradelli, L. ; Pinciroli, M...
Value in Health. 26 (2023) 12 - p. S144 , 2023

Link: https://doi.org/10.1016/..

5

EE115 Cost-Effectiveness and Cost-Utility Analyses of Polat..:

Bellone, M ; Pradelli, L ; Ghislieri, D
Value in Health. 25 (2022) 12 - p. S75-S76 , 2022

Link: https://doi.org/10.1016/..

6

POSA108 A Budget Impact Analysis of Atezolizumab Monotherap..:

Pradelli, L ; Bellone, M ; Heaton, E...
Value in Health. 25 (2022) 1 - p. S54 , 2022

Link: https://doi.org/10.1016/..

7

EE223 Economic Consequences of Administering Obinutuzumab a..:

Bellone, M ; Pradelli, L ; Tavarozzi, R...
Value in Health. 25 (2022) 12 - p. S97 , 2022

Link: https://doi.org/10.1016/..

8

POSB108 Cost-Effectiveness and Cost-Utility Analyses of Ate..:

Pradelli, L ; Bellone, M ; Sanchez Alvarez, J..
Value in Health. 25 (2022) 1 - p. S82 , 2022

Link: https://doi.org/10.1016/..

9

EE177 A Budget Impact Analysis of a Novel Diagnostic Test t..:

Porta, C ; Pradelli, L ; Povero, M..
Value in Health. 25 (2022) 12 - p. S87-S88 , 2022

Link: https://doi.org/10.1016/..

10

EE647 Real-Word Effectiveness and Cost Consequence of Antip..:

Pradelli, L ; Zaniolo, O ; Povero, M...
Value in Health. 25 (2022) 12 - p. S183 , 2022

Link: https://doi.org/10.1016/..

11

HPR159 Neovascular Age-Related Macular Degeneration (NAMD) ..:

Fasci, A ; Pradelli, L
Value in Health. 25 (2022) 12 - p. S261 , 2022

Link: https://doi.org/10.1016/..

12

POSB109 Cost-Effectiveness and Cost-Utility Analyses of Pol..:

Bellone, M ; Pradelli, L ; Caputo, A...
Value in Health. 25 (2022) 1 - p. S82 , 2022

Link: https://doi.org/10.1016/..

13

POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzuma..:

Bellone, M ; Pradelli, L ; Sanfilippo, A...
Value in Health. 25 (2022) 1 - p. S109 , 2022

Link: https://doi.org/10.1016/..

14

POSB72 Subcutaneous Daratumumab in the Treatment of Multipl..:

Ghetti, G ; Pradelli, L ; Crovato, E.
Value in Health. 25 (2022) 1 - p. S74 , 2022

Link: https://doi.org/10.1016/..

15

EE107 Ponesimod Indicated for Patients With Active Relapsin..:

Bellone, M ; Pradelli, L ; Rizzato, M.
Value in Health. 25 (2022) 12 - p. S74 , 2022

Link: https://doi.org/10.1016/..